Segment disclosures

Company overview

APPLIED UV, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

3 dimension combinations 52 retained observations 15 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Disinfectant Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=auvi:DisinfectantSegmentMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-3119701426 USD20240416Open filing evidence
2023-07-01 – 2023-09-305730694 USD20231117Open filing evidence
2023-01-01 – 2023-09-3015999808 USD20231117Open filing evidence
2023-04-01 – 2023-06-305696004 USD20230818Open filing evidence
2023-01-01 – 2023-06-3010269114 USD20230818Open filing evidence
2023-01-01 – 2023-03-314573110 USD20230522Open filing evidence
2022-01-01 – 2022-12-316500479 USD20240416Open filing evidence
2022-07-01 – 2022-09-301593581 USD20231117Open filing evidence
2022-01-01 – 2022-09-305278955 USD20231117Open filing evidence
2022-04-01 – 2022-06-301738534 USD20230818Open filing evidence
2022-01-01 – 2022-06-303685374 USD20230818Open filing evidence
2022-01-01 – 2022-03-311946840 USD20230522Open filing evidence
2021-01-01 – 2021-12-315723915 USD20230331Open filing evidence
2021-07-01 – 2021-09-301801337 USD20221114Open filing evidence
2021-01-01 – 2021-09-303465803 USD20221114Open filing evidence
2021-04-01 – 2021-06-30919702 RestatedUSD20220815Open filing evidence
2021-01-01 – 2021-06-301664466 RestatedUSD20220815Open filing evidence
2021-01-01 – 2021-03-31744764 USD20220523Open filing evidence

Hospitality Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=auvi:HospitalitySegmentMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-3121016762 USD20240416Open filing evidence
2023-07-01 – 2023-09-305715354 USD20231117Open filing evidence
2023-01-01 – 2023-09-3016944409 USD20231117Open filing evidence
2023-04-01 – 2023-06-305147682 USD20230818Open filing evidence
2023-01-01 – 2023-06-3011229055 USD20230818Open filing evidence
2023-01-01 – 2023-03-316081373 USD20230522Open filing evidence
2022-01-01 – 2022-12-3113639370 USD20240416Open filing evidence
2022-07-01 – 2022-09-304282030 USD20231117Open filing evidence
2022-01-01 – 2022-09-309860392 USD20231117Open filing evidence
2022-04-01 – 2022-06-304169112 USD20230818Open filing evidence
2022-01-01 – 2022-06-305578362 USD20230818Open filing evidence
2022-01-01 – 2022-03-311409250 USD20230522Open filing evidence
2021-01-01 – 2021-12-315943664 USD20230331Open filing evidence
2021-07-01 – 2021-09-301750227 USD20221114Open filing evidence
2021-01-01 – 2021-09-304282696 USD20221114Open filing evidence
2021-04-01 – 2021-06-30964618 USD20220815Open filing evidence
2021-01-01 – 2021-06-302532469 USD20220815Open filing evidence
2021-01-01 – 2021-03-311567851 USD20220523Open filing evidence
2020-01-01 – 2020-12-315732734 RestatedUSD20220407Open filing evidence
2020-07-01 – 2020-09-301560633 USD20211115Open filing evidence
2020-01-01 – 2020-09-304727631 USD20211115Open filing evidence
2019-01-01 – 2019-12-3186736 USD20210330Open filing evidence

Corporate

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-300 USD20231117Open filing evidence
2023-01-01 – 2023-09-300 USD20231117Open filing evidence
2023-04-01 – 2023-06-300 USD20230818Open filing evidence
2023-01-01 – 2023-06-300 USD20230818Open filing evidence
2023-01-01 – 2023-03-310 USD20230522Open filing evidence
2022-01-01 – 2022-12-310 USD20230331Open filing evidence
2022-07-01 – 2022-09-300 USD20231117Open filing evidence
2022-01-01 – 2022-09-300 USD20231117Open filing evidence
2022-04-01 – 2022-06-300 USD20230818Open filing evidence
2022-01-01 – 2022-06-300 USD20230818Open filing evidence
2022-01-01 – 2022-03-310 USD20230522Open filing evidence
2021-01-01 – 2021-12-310 USD20230331Open filing evidence